On the Horizon: Asciminib, a New Drug for Treating R/R CML ...Middle East

News by : (Medscape) -
A first-in-class STAMP inhibitor, asciminib, shows better efficacy than bosutinib in patients with relapsed/refractory chronic myeloid leukemia in the chronic phase. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( On the Horizon: Asciminib, a New Drug for Treating R/R CML )

Also on site :

Most Viewed News
جديد الاخبار